Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems

By sjmartinez • June 13, 2025

Low YS, Jackson ML, Hyde RJ, Brown RE, Sanghavi NM, Baldwin JD, Pike CW, Muralidharan J, Hui G, Alexander N, Hassan H, Nene RV, Pike M, Pokrzywa CJ, Vedak S, Yan AP, Yao DH, Zipursky AR, Dinh C, Ballentine P, Derieg DC, Polony V, Chawdry RN, Davies J, Hyde BB, Shah NH, Gombar S. Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems. Digit Health. 2025 Jun 9;11:20552076251348850. doi: 10.1177/20552076251348850. PMID: 40510193; PMCID: PMC12159471.

Tags: Artificial intelligence, Cohort study, evidence-based medicine, Fellow, Hematology/Oncology, Large language models, Publications, retrieval-augmented generation

Response to Letter to the Editor: ‘NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial’

Macarulla T, Cid RP, Womack MS, Gracian AC, Zervoudakis A, Hatoum H, Chung V, Patel A, Paulson AS, Pant S, O'Reilly EM, Hubner RA, Van[...]

Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivity

Heskett MB, Vouzas AE, Johnstone B, Freese KP, Yates PA, Copenhaver PF, Spellman PT, Gilbert DM, Thayer MJ. Autosomal allelic inactivation at loci with variable[...]

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma)

Shin SJ, Lee JL, Powles T, Martin-Liberal J, Morales-Barrera R, Drakaki A, Friedlander T, Joly F, Shah SA, Vuky J, Ianculescu I, Michielin F, Gan[...]